American Journal of Obstetrics & Gynecology
Volume 198, Issue 3 , Pages 248-253 , March 2008

Contraceptive efficacy of intrauterine devices

  • Patrick F. Thonneau, MD, MSc

      Affiliations

    • Corresponding Author InformationReprints: Patrick F. Thonneau, MD, MSc, Equipe d’accueil EA 3694 - Recherche en Fertilité Humaine, Hôpital Paule de Viguier - Service d’Urologie-Andrologie, 330, avenue de Grande Bretagne, TSA 70034 - 31059, Toulouse cedex 9, France
    • ,
  • Thierry E. Almont, MD

Received 7 July 2007 ,Accepted 1 October 2007.

References 

  1. d’Arcanges C. Worldwide use of intrauterine devices for contraception. Contraception. 2007;75:S2–S7
  2. Mosher WD, Martinez GM, Chandra A, Abma J, Willson SJ. Use of contraception use of family planning services in the United States: 1982-2002. Adv Data. 2004;10:1–36
  3. US Department of Health and Human Services/Centers for Disease Control and Prevention / National Center for Health Statistics. Fertility, family planning, and reproductive health of US women: data from the 2002 national survey of family growth (Vital and Health Statistics, series 23, no. 25). Hyattsville (MD): DHHS Publication; 2005;
  4. Avecilla-Palau A, Moreno V. Uterine factors and risk of pregnancy in IUD users: a nested case-control study. Contraception. 2003;67:235–239
  5. Thonneau P, Goulard H, Goyaux N. Risk factors for intrauterine device failure: a review. Contraception. 2001;64:33–37
  6. Tatum HJ. Intrauterine contraception. Am J Obstet Gynecol. 1972;112:1000–1023
  7. Sivin I, Greenslade F, Schmidt F, Waldman S. The copper T380 intrauterine device: a summary of scientific data. New York: The Population Council Inc; 1992;
  8. United Nations Development Programme, United Nations Population Fund, World Health OrganizationThe TCu 380A IUD and the frameless IUD “the FlexiGard”: interim three-year data from an international multicenter trial: UNDP, UNFPA, and WHO Special Programme of Research, Development and Research Training in Human Reproduction, World Bank: IUD research group. Contraception. 1995;52:77–83
  9. United Nations Development Programme, United Nations Population Fund, World Health Organization. Long-term reversible contraception: twelve years of experience with the TCu380A and TCu220C. Contraception. 1997;56:341–352
  10. United Nations Development Programme, United Nations Population Fund, World Health Organization. A randomized multicentre trial of the Multiload 375 and TCu380A IUDs in parous women: three-year results: UNDP/UNFPA/WHO/World Bank, Special Programme of Research, Development and Research Training in Human Reproduction: IUD research group. Contraception. 1994;49:543–549
  11. World Health Organization. The TCu380A, TCu220C, multiload 250 and Nova T IUDS at 3,5 and 7 years of use: results from three randomized multicentre trials: World Health Organization, Special Programme of Research, Development and Research Training in Human Reproduction: Task Force on the Safety and Efficacy of Fertility Regulating Methods. Contraception. 1990;42:141–158
  12. Kulier R, Helmerhorst FM, O’Brien P, Usher-Patel M, d’Arcangues C. Copper containing, framed intra-uterine devices for contraception. Cochrane Database Syst Rev. 2006;3:CD005347
  13. Bahamondes L, Diaz J, Petta C, Monteiro I, Monteiro CD, Regina CH. Comparison of the performances of TCu380A and TCu380S IUDs up to five years. Adv Contracept. 1999;15:275–281
  14. Baveja R, Bichille LK, Coyaji KJ, et al. Randomized clinical trial with intrauterine devices (levonorgestrel intrauterine device (LNG), CuT 380Ag, CuT 220C and CuT 200B): a 36-month study: Indian Council of Medical Research Task Force on IUD. Contraception. 1989;39:37–52
  15. Cole LP, Potts DM, Aranda C, et al. An evaluation of the TCu 380Ag and the Multiload Cu375. Fertil Steril. 1985;43:214–217
  16. Farr G, Amatya R. Contraceptive efficacy of the copper T 380A and copper T 200 intrauterine devices: results from a comparative clinical trial in six developing countries. Contraception. 1994;49:231–243
  17. Sastrawinata S, Farr G, Prihadi SM, et al. A comparative clinical trial of the TCu 380A, Lippes Loop D and Multiload Cu 375 IUDs in Indonesia. Contraception. 1991;44:141–154
  18. Shrestha M, Hurst C, Farr G, Amatya R, Tucker B, McMaham J. A comparative study of the TCu 380A versus TCu 200 IUDs in Nepal. Asia Pac Popul J. 1995;10:15–26
  19. Sivin I, Stern J. Long-acting, more effective copper T IUDs: a summary of US experience, 1970-75. Stud Fam Plann. 1979;10:263–281
  20. Sivin I, Diaz J, Alvarez F, et al. Four-year experience in a randomized study of the Gyne T 380 Slimline and the Standard Gyne T 380 intrauterine copper devices. Contraception. 1993;47:37–42
  21. Sivin I, Diaz S, Pavez M, et al. Two-year comparative trial of the Gyne T* 380 Slimline and Gyne T* 380 intrauterine copper devices. Contraception. 1991;44:481–487
  22. Sivin I, Shaaban M, Odlind V, et al. A randomized trial of the Gyne T 380 and Gyne T 380 Slimline intrauterine copper devices. Contraception. 1990;42:379–389
  23. Van Kets HE, Van der Pas H, Delbarge W, Thiery M. A randomized comparative study of the TCu380A and Cu-Safe 300 IUDs. Adv Contracept. 1995;11:123–129
  24. Bratt H, Skjeldestad FE, Cullberg Valentin K. A randomized trial of three copper IUDs (MLCu250, MLCu375 and Nova-T). Acta Obstet Gynecol Scand. 1988;67:247–251
  25. Ho J, Wu Z, Cai S, et al. A randomized comparative trial of the MLCu375, TCu220C, steel ring and uterine cavity-shaped IUDs. Adv Contracept. 1992;8:161–166
  26. Saure A, Hirvonen E, Kivijärvi A, Timonen H. Comparative performance of Fincoid, Nova-T and MLCu375 IUDs: intrauterine contraception: advances and future prospects. Philadelphia: Harper & Row; 1985;
  27. Wilson JC. A New Zealand randomized comparative study of three IUDs (Nova-T, MLCu375, MLAgCu250): 1-, 2- and 3-year results. Adv Contracept. 1992;8:153–159
  28. Farr G, Amatya R. Contraceptive efficacy of the Copper T380A and the multiload Cu250 IUD in three developing countries. Adv Contracept. 1994;10:137–149
  29. Rowe PJ, Boccard S, Farley TMM, Peregoudov S. Long-term reversible contraception: twelve years of experience with the TCu380A and TCu220C. Contraception. 1997;56:341–352
  30. Bahamondes L, Faundes A, Sobreira-Lima B, Lui-Filho JF, Pecci P, Matera S. TCu380A IUD: a reversible permanent contraceptive method in women over 35 years of age. Contraception. 2005;72:337–341
  31. Sivin I. Utility and drawbacks of continuous use of a copper T IUD for 20 years. Contraception. 2007;75:S70–S75
  32. Baeyertz JD, Hartfield VJ. The Nova-T 200 intrauterine contraceptive device: a 12 year study. N Z Med J. 1997;110:169–171
  33. Batar I, Kuukankorpi A, Siljander M, Elomaa K, Rauramo I. Five-year clinical experiences with NOVA T 380 copper IUD. Contraception. 2002;66:309–314
  34. Cao X, Zhang W, Gao G, Van Kets H, Wildemeersch D. Randomized comparative trial in parous women of the frameless GyneFix and the TCu380A intrauterine devices: long-term experience in a Chinese family planning clinic. Eur J Contracept Reprod Health Care. 2000;5:135–140
  35. Cao X, Zhang W, Zhao X, et al. Three-year efficacy and acceptability of the GyneFix 200 intrauterine system. Contraception. 2004;69:207–211
  36. Wu S, Hu J, Wildemeersch D. Performance of the frameless GyneFix and the TCu380A IUDs in a 3-year multicenter, randomized, comparative trial in parous women. Contraception. 2000;61:91–98
  37. Dennis J, Webb A, Kishen M. Expulsions following 1000 GyneFix insertions. J Fam Plann Reprod Health Care. 2001;27:135–138
  38. Wildemeersch D. New frameless and framed intrauterine devices and systems: an overview. Contraception. 2007;75:S82–S92
  39. Sivin I, Stern J, Coutinho E, et al. Prolonged intrauterine contraception: a seven-year randomized study of the levonorgestrel 20 mcg/day (LNg 20) and the Copper T380 Ag IUDS. Contraception. 1991;44:473–480
  40. Diaz J, Faundes A, Diaz M, Marchi N. Evaluation of the clinical performance of a levonorgestrel-releasing IUD, up to seven years of use, in Campinas, Brazil. Contraception. 1993;47:169–175
  41. Ronnerdag M, Odlind V. Health effects of long-term use of the intrauterine levonorgestrel-releasing system: a follow-up study over 12 years of continuous use. Acta Obstet Gynecol Scand. 1999;78:716–721
  42. French RS, Cowan FM, Mansour D, et al. Levonorgestrel-releasing (20 microgram/day) intrauterine systems (Mirena) compared with other methods of reversible contraceptives. BJOG. 2000;107:1218–1225
  43. French R, Van Vliet H, Cowan F, et al. Hormonally impregnated intrauterine systems (IUSs) versus other forms of reversible contraceptives as effective methods of preventing pregnancy. Cochrane Database Syst Rev. 2004;CD001776
  44. Backman T, Rauramo I, Huhtala S, Koskenvuo M. Pregnancy during the use of levonorgestrel intrauterine system. Am J Obstet Gynecol. 2004;190:50–54
  45. Thonneau P, Almont T, de La Rochebrochard E, Maria B. Risk factors for IUD failure: results of a large multicentre case-control study. Hum Reprod. 2006;21:2612–2616
  46. Papiernik E, Rozenbaum H, Amblard P, Dephot N, de Mouzon J. Intra-uterine device failure: relation with drug use. Eur J Obstet Gynecol Reprod Biol. 1989;32:205–212
  47. Grimes D, Schulz K, Stanwood N. Immediate postabortal insertion of intrauterine devices. Cochrane Database Syst Rev. 2004;CD001777
  48. Celen S, Moroy P, Sucak A, Aktulay A, Danisman N. Clinical outcomes of early postplacental insertion of intrauterine contraceptive devices. Contraception. 2004;69:279–282
  49. Eroglu K, Akkuzu G, Vural G, et al. Comparison of efficacy and complications of IUD insertion in immediate postplacental/early postpartum period with interval period: 1 year follow-up. Contraception. 2006;74:376–381
  50. Ortayli N, Bulut A, Sahin T, Sivin I. Immediate postabortal contraception with the levonorgestrel intrauterine device, Norplant, and traditional methods. Contraception. 2001;63:309–314
  51. Pakarinen P, Toivonen J, Luukkainen T. Randomized comparison of levonorgestrel- and copper-releasing intrauterine systems immediately after abortion, with 5 years’ follow-up. Contraception. 2003;68:31–34
  52. Gottardi G, Spreafico A, de Orchi L. The postcoital IUD as an effective continuing contraceptive method. Contraception. 1986;34:549–558
  53. Bilian X. Chinese experience with intrauterine devices. Contraception. 2007;75:S31–S34
  54. Trussell J, Ellertson C. Efficacy of emergency contraception. Fertil Control Rev. 1995;4:2–11
  55. Zhou L, Xiao B. Emergency contraception with multiload Cu-375 SL IUD: a multicenter clinical trial. Contraception. 2001;64:107–112

PII: S0002-9378(07)01984-9

doi: 10.1016/j.ajog.2007.10.787

American Journal of Obstetrics & Gynecology
Volume 198, Issue 3 , Pages 248-253 , March 2008

Article Tools